Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » By Affiliations
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top 20 Journal Cited
 » Top 20 Cited
 » Top 20 Author Cited
 » Usage Since Sept 2007


 
 
 

Login | Create Account

The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion

Sthaneshwar, Pavai, and Yap, Sook Fan, and Jayaram, Gita, (2002) The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion. CEA and CA-125 in Pleural Effusion, 24 (1). pp. 53-58.

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
197Kb

Official URL: http://www.mjpath.org.my/past_issue/MJP2002.1/The%20diagnostic%20usefulness%20of%20tumour%20markers%20CEA%20and%20CA-125%20in%20pleural%20effusion.pdf

Affiliations

University of Malaya. Faculty of Medicine. Dept. of Pathology

Abstract

Pleural effusion is a common diagnostic problem. The analysis of serum and pleural fluid for tumour markers is widely used as a diagnostic aid in clinical practice. The aim of the present study was to determine the usefulness of simultaneous quantification of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA-125) in distinction of malignant from benign effusion. Data from a total of 78 patients including 53 patients with benign and 25 patients with malignant effusion was evaluated. The cut-off values for differentiating benign from malignant effusions were determined using results obtained from patients with known benign effusions (mean + 2 SD, 95% confidence interval). The cut-off for CEA and CA-125 were S.lng/ml and 1707 IU/ml respectively. CEA assay in pleural fluid had an acceptable sensitivity and good specificity of 64% and 98% respectively. CA- 125 had a sensitivity of 36% and specificity of 94%. The combination of the two tumour markers gave a sensitivity of 72% and specificity of 92.4%. We suggest a good clinical strategy may be to begin with CEA measurement (assay specificity 98%); if CEA is below the cut-off value (negative), CA-125 could then be measured to improve the sensitivity of detection of malignant effusions. However, measurement of these tumour markers is not cost effective from the point of view that it does not give information on the type of malignancy present. The latter has to be determined either by histological or cytological study.

Item Type:Journal
Keywords:Pleural effusion, tumour marker, carcinoembryonic antigen(CEA), carbohydrate antigen(CA- 125)
Subjects:R Medicine
ID Code:1824

1. Johnston WW. The malignant pleural effusion: a review of the cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985; 56: 905-9.

2. Heffner JE, Brown LK, Barbieri C. Diagnostic value of tests that discriminate exudative and transudative pleural effusions. Primary Study Investigators. Chest 1997; 11 1:970-80.

3. Wardman AG, Bowen M, Struthers LP. The diagnosis of pleural effusions: are cancer markers clinically helpful? Med Paediatr Oncol 1984; 12:68-72.

4. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and application. Ann Intern Med 1981; 94557-92.

5. Villena V, Lopez-Encuentra A, Echave-Sustaeta J. Diagnostic value of CA 72-4, carcinembryonic antigen, CA 15-3 and CA19-9 assay in pleural fluid. Cancer 1996; 78:736-40.

6. Salama G, Miedouge G et al. Evaluation of pleural CYFRA 21 - 1 and CEA in the diagnosis of malignant pleural effusion. Br J cancer 1998; 77:472-6.

7. Vergote I, Onsrud M, Bormer OP. CA-125 in peritonea1 fluid of ovarian cancer patients. Gynecol Oncol 1992; 44: 161-5.

8. Lindgren J, Kuusela P, Hellstrom PE. Ovarian cancer antigen CA-125 in patients with pleural effusions. Eur J Cancer Clin Oncol 1988; 24:737-9.

9. Merger J, Pemanetter W, Gerbes AL et al. Tumour associated antigens in diagnosis of serous effusion. J Clin Pathol 1988; 41:633-43.

10. Kandylis K, Vassilomanolakis M, Baziotis N. Diagnostic significance of the tumour markers CEA, CA15-3 and CA-125 in malignant effusion in breast cancer. Ann Oncol 1990: 1:435-8.

11. Filiz Kuralay, Zeynep Togoz, Abdurrahaman Comlekci. Diagnostic usefulness of tumour marker levels in pleural effusion. Clin Chem Acta 2000; 300:43-55.

12. Chretien J, Pleural response in malignat metastatic tumours. In: Chretien J, Bignos J, Hirsch A, ditors. The pleura in health and diseases. New York: Marcel Dekker, 1985:489-505.

Repository Staff Only: item control page